Cadent Therapeutics

eraser pencil mistake write cut pen scrub out
Biotech

Novartis cuts depression study, erasing Cadent buy from pipeline

Novartis has terminated a phase 2 depression trial, nearly erasing the 2020 buy of Cadent Therapeutics from its pipeline.
Gabrielle Masson Oct 10, 2023 10:52am
Novartis

Novartis snaps up neuro partner Cadent for $210M upfront

Dec 17, 2020 1:15am